In general, it has been proved that FBXO17 is overexpressed in many kinds of tumors, like glioma [15], HCC [43], lung adenocarcinoma [16] and esophageal squamous cell carcinoma [44]. Here, FBXO17 is linked to hepatocellular carcinoma.